96 related articles for article (PubMed ID: 35961028)
21. High Prevalence of Active Tuberculosis in Adults and Children with Idiopathic Inflammatory Myositis as Compared with Systemic Lupus Erythematosus in a Tuberculosis Endemic Country: Retrospective Data Review from a Tertiary Care Centre in India.
Gupta L; Aggarwal R; Naveen R; Lawrence A; Zanwar A; Misra DP; Agarwal V; Misra R; Aggarwal A
Mediterr J Rheumatol; 2021 Jun; 32(2):134-142. PubMed ID: 34447909
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated myositis before and after the COVID-19 pandemic onset: a changing trend.
Costa FM; Campanilho-Marques R; Dourado E; Bandeira M; Correia B; Melo AT; Saraiva F; Barreira SC; Fonseca JE
Clin Exp Rheumatol; 2024 Feb; 42(2):316-320. PubMed ID: 38488097
[TBL] [Abstract][Full Text] [Related]
23. The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies.
Skarlis C; Michalakeas N; Gerochristou M; Raftopoulou S; Marketos N; Boki K; Vassilopoulos D; Stratigos AP; Boumpas D; Mavragani C
Mediterr J Rheumatol; 2023 Jun; 34(2):275-278. PubMed ID: 37654645
[TBL] [Abstract][Full Text] [Related]
24. Update on outcome assessment in myositis.
Rider LG; Aggarwal R; Machado PM; Hogrel JY; Reed AM; Christopher-Stine L; Ruperto N
Nat Rev Rheumatol; 2018 May; 14(5):303-318. PubMed ID: 29651119
[TBL] [Abstract][Full Text] [Related]
25. Peripheral Blood Lymphocyte Subsets and Heterogeneity of B Cell Subsets in Patients of Idiopathic Inflammatory Myositis with Different Myositis-specific Autoantibodies.
Pan Z; Li M; Zhang P; Li T; Liu R; Liu J; Liu S; Zhang Y
Inflammation; 2024 May; ():. PubMed ID: 38755405
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Yield of Computed Tomography for Cancer Detection in a Tertiary Referral Population of Idiopathic Inflammatory Myositis Patients.
Mecoli CA; Chee B; Chen M; Wang X; Albayda J; Paik JJ; Tiniakou E; Adler B; Kelly W; Mammen AL; Platz EA; Casciola-Rosen L; Christopher-Stine L; Shah AA
Arthritis Care Res (Hoboken); 2023 Oct; 75(10):2142-2150. PubMed ID: 36913182
[TBL] [Abstract][Full Text] [Related]
27. Update in juvenile myositis.
Nistala K; Wedderburn LR
Curr Opin Rheumatol; 2013 Nov; 25(6):742-6. PubMed ID: 24061078
[TBL] [Abstract][Full Text] [Related]
28. Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care.
Papadopoulou C; Chew C; Wilkinson MGL; McCann L; Wedderburn LR
Nat Rev Rheumatol; 2023 Jun; 19(6):343-362. PubMed ID: 37188756
[TBL] [Abstract][Full Text] [Related]
29. Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19.
Wu W; Wang R; Xie C; Chen Y; Teng X; Sun S; Xu W; Fu Y; Ma Y; Xu A; Lyu X; Ye Y; Li J; Zhang C; Shen N; Wang X; Ye S; Fu Q
Front Immunol; 2024; 15():1295472. PubMed ID: 38500883
[TBL] [Abstract][Full Text] [Related]
30. Long Term Outcomes in Idiopathic Inflammatory Myositis: An Observational Epidemiologic Study over 15 Years.
Janardana R; Kn S; Bhat V; Balakrishnan D; Raj JM; Pinto B; K C; Nadig R; Mahadevan A; Shobha V
Mediterr J Rheumatol; 2023 Dec; 34(4):513-524. PubMed ID: 38282927
[TBL] [Abstract][Full Text] [Related]
31. International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.
Oldroyd AGS; Callen JP; Chinoy H; Chung L; Fiorentino D; Gordon P; Machado PM; McHugh N; Selva-O'Callaghan A; Schmidt J; Tansley SL; Vleugels RA; Werth VP; ; Aggarwal R
Nat Rev Rheumatol; 2023 Dec; 19(12):805-817. PubMed ID: 37945774
[TBL] [Abstract][Full Text] [Related]
32. Mental health in paediatric and adult myositis-related diseases: current state of research, interventions, and future steps from the MIHRA Psychological Impact Scientific Working Group.
Lanis A; Alexanderson H; Ardalan K; Edison S; Graham CD; de Groot I; Gupta L; Kim S; Knight AM; Kobert L; Livermore P; Lood C; Pilkington C; Regardt M; Rubinstein TB; Shenoi S; Turnier L; Voet NBM; Wahezi DM; Saketkoo LA
Clin Exp Rheumatol; 2024 Feb; 42(2):413-424. PubMed ID: 38488093
[TBL] [Abstract][Full Text] [Related]
33. Insights into juvenile myositis via engineered muscle.
Kim H
Nat Rev Rheumatol; 2023 Sep; 19(9):543-544. PubMed ID: 37495869
[No Abstract] [Full Text] [Related]
34. Correction to: Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.
Chen X; Yu Y; Su Y; Shi L; Xie S; Hong Y; Liu X; Yin F
Funct Integr Genomics; 2024 May; 24(3):96. PubMed ID: 38740604
[No Abstract] [Full Text] [Related]
35. Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies.
Choi MY; Satoh M; Fritzler MJ
Curr Opin Rheumatol; 2023 Nov; 35(6):383-394. PubMed ID: 37503636
[TBL] [Abstract][Full Text] [Related]
36. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features.
Sherman MA; Graf R; Sabbagh SE; Galindo-Feria AS; Pinal-Fernandez I; Pak K; Kishi T; Flegel WA; Targoff IN; Miller FW; Lundberg IE; Rider LG; Mammen AL;
Rheumatology (Oxford); 2023 Feb; 62(SI2):SI226-SI234. PubMed ID: 35961028
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort.
Galindo-Feria AS; Horuluoglu B; Day J; Fernandes-Cerqueira C; Wigren E; Gräslund S; Proudman S; Lundberg IE; Limaye V
Rheumatology (Oxford); 2022 Oct; 61(10):4145-4154. PubMed ID: 35022656
[TBL] [Abstract][Full Text] [Related]
38. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
Sabbagh S; Pinal-Fernandez I; Kishi T; Targoff IN; Miller FW; Rider LG; Mammen AL;
Ann Rheum Dis; 2019 Jul; 78(7):988-995. PubMed ID: 31018961
[TBL] [Abstract][Full Text] [Related]
39. Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.
Albrecht I; Wick C; Hallgren Å; Tjärnlund A; Nagaraju K; Andrade F; Thompson K; Coley W; Phadke A; Diaz-Gallo LM; Bottai M; Nennesmo I; Chemin K; Herrath J; Johansson K; Wikberg A; Ytterberg AJ; Zubarev RA; Danielsson O; Krystufkova O; Vencovsky J; Landegren N; Wahren-Herlenius M; Padyukov L; Kämpe O; Lundberg IE
J Clin Invest; 2015 Dec; 125(12):4612-24. PubMed ID: 26551678
[TBL] [Abstract][Full Text] [Related]
40. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
